Skip to main content

Erdanib 4 mg & 5 mg (Erdafitinib)

Erdafitinib can cause adverse reactions affecting the eyes, mouth, skin, nails, gastrointestinal system and laboratory parameters. The likelihood and severity vary among patients.

Commonly reported adverse reactions

Current prescribing information identifies adverse reactions including:

  • Hyperphosphatemia
  • Diarrhea
  • Stomatitis
  • Dry mouth
  • Nail disorders
  • Palmar-plantar erythrodysesthesia syndrome
  • Decreased appetite
  • Taste disturbance
  • Dry skin
  • Alopecia
  • Constipation
  • Increased liver enzymes
  • Eye disorders

Important adverse effects

Adverse effectWhy it matters
HyperphosphatemiaMay require monitoring and treatment adjustment
Ocular toxicityCan affect vision and retinal structures
Retinal pigment epithelial detachmentRequires ophthalmic evaluation and management
StomatitisMouth inflammation can interfere with eating and comfort
Nail disordersNail-bed and nail-plate changes can develop
Palmar-plantar erythrodysesthesiaCan cause discomfort involving hands and feet
DiarrheaCan become clinically significant
Dry mouthMay contribute to oral discomfort
Skin effectsCan include dryness and other dermatologic reactions

Ocular toxicity

Erdafitinib can cause central serous retinopathy or retinal pigment epithelial detachment. Visual symptoms should be reported promptly rather than monitored at home without professional assessment.

Hyperphosphatemia

FGFR inhibition can increase serum phosphate. This effect is clinically relevant to dosing because phosphate measurements are used when deciding whether to increase the starting dose.

Nail and skin effects

Nail dystrophy, onycholysis and hand-foot syndrome are recognized treatment-related problems. These effects may require supportive care or dose modification depending on severity.

When urgent medical assessment may be needed

Prompt medical attention is appropriate for significant visual changes, severe eye pain, sudden vision loss, severe weakness, severe diarrhea, serious skin reactions, difficulty swallowing, severe mouth inflammation or other symptoms that may represent significant toxicity.